  |
| Health |
| | Coronavirus Briefing: Vaccines Counter Dominant Virus Variant in U.S. |
|
|
| Good afternoon. The highly contagious U.K. variant of the Covid-19 virus, now the dominant virus strain in the U.S., is making the pandemic harder to control. But it comes with a silver lining: The authorized vaccines work well against it. Also in today's edition: How the vaccine makers depend on each other for key ingredients. If someone forwarded today's briefing, we invite you to sign up here. |
|
| | ✔️ Today's Main Takeaways |
|
|
- U.S. to restrict travel from India
- Vaccines are effective against B.1.1.7, the dominant strain of Covid-19 in the U.S.
- U.S. companies are scrambling to meet a surge in demand
|
|
| The U.S. will restrict travel from India starting Tuesday, as concerns mount over a record surge in coronavirus cases there. (full story) Authorized vaccines are effective against the dominant strain of Covid-19 in the U.S. and health authorities say the shots are starting to slow down cases. (full story) Supply-chain snarls and labor shortages are crimping some businesses looking to ride a rebound in the U.S. economy. (full story) |
|
| |
| |
| |
| |
| How a More Resilient America Beat a Midcentury Pandemic: In 1957, the U.S. rose to the challenge of the “Asian flu” with stoicism and a high tolerance for risk, writes historian Niall Ferguson. |
|
|
| |
| |
| 243,463,471 | vaccine doses given so far in the U.S. |
|
|
| 45,303 | new U.S. cases recorded yesterday |
|
|
| 702 | deaths in the U.S. recorded yesterday |
|
|
| 576,770 | total U.S. deaths |
|
|
| 32,396,973 | total confirmed cases in the U.S. |
|
|
| 152,323,047 | confirmed cases world-wide, and 3,195,085 deaths |
|
|
| Sources: Johns Hopkins University as of 11:30 a.m. ET; Vaccination figures from the Centers for Disease Control and Prevention. |
|
| |
| |
| Covid-19 Vaccine Producers Rely on Each Other for Key Ingredients: Vaccine makers depend on each other for the essential ingredients to produce the shots. Trade experts warn that restrictions on vaccine exports risk squeezing production just when it is needed most. |
|
|
| Israel Rolls Out Covid-19 Passport Program to Children: Under the program, children with negative PCR tests will be eligible for a three-day so-called green passport that will be associated with their parents’ passes. |
|
|
| Shares of Oxford-AstraZeneca Covid-19 Vaccine Startup Trade Down in Debut: Vaccitech, a British company that co-invented the AstraZeneca Covid-19 vaccine, closed its first day of trading with shares down 17%. |
|
|
| |
| Cargo Pants and Outdoor Slippers Are Hot, as Americans Return to Stores: People are dressing up again—sort of—as they get vaccinated, venture out to social events and prepare to return to work, and the fashion industry is preparing for a major surge in sales. |
|
|
| |
| Today’s newsletter was curated and edited by Todd Olmstead in London. Let us know what you think by replying to this email. |
|
| |
